These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Leukemia AND IGH AND Diagnosis
282 results:

  • 1. MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Translocations as Targets for Real-Time Quantitative PCR and ddPCR.
    Pott C; Brüggemann M; Ritgen M; van der Velden VHJ; van Dongen JJM
    Methods Mol Biol; 2025; 2865():189-219. PubMed ID: 39424725
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The clinical utility of plasma circulating tumor DNA in the diagnosis and disease surveillance in non-diffuse large B-cell non-Hodgkin lymphomas.
    Zhang X; Yang L; Zhu M; Zhao X; Xiao Y; Pang J; Zhu L; Ou Q; Ni HW; Xu J
    Future Oncol; 2024; 20(38):3107-3117. PubMed ID: 39417339
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Splenic marginal zone lymphoma with prolymphocytic transformation and cyclin D1 expression in the absence of CCND1 rearrangement.
    Elbaz Younes I; Bunting ST; Zhang X
    Int J Hematol; 2024 Dec; 120(6):750-754. PubMed ID: 39285033
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Laboratory validation and clinical utility of next-generation sequencing-based igh/TCR clonality testing for the monitoring of measurable residual disease in acute lymphoblastic leukaemia: real-world experience at Austin Pathology.
    Ma SB; Lin W; Campbell J; Clerici K; White D; Yeung D; Gorniak M; Fleming S; Fong CY; Agarwal R
    Pathology; 2024 Dec; 56(7):982-992. PubMed ID: 39025724
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. IKZF1
    Kovach AE; Wengyn M; Vu MH; Doan A; Raca G; Bhojwani D
    Pediatr Blood Cancer; 2024 Jul; 71(7):e30996. PubMed ID: 38637852
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. B cell receptor signaling proteins as biomarkers for progression of CLL requiring first-line therapy.
    Vervoordeldonk MYL; Hengeveld PJ; Levin MD; Langerak AW
    Leuk Lymphoma; 2024 Aug; 65(8):1031-1043. PubMed ID: 38619476
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Optical genomic mapping is a helpful tool for detecting CCND1 rearrangements in CD5-negative small B-cell lymphoma: Two cases of leukemic non-nodal mantle cell lymphoma.
    Quesada AE; Hu S; Li S; Toruner GA; Wei Q; Loghavi S; Ok CY; Jain P; Thakral B; Nwogbo OV; Kim D; Iyer SP; You MJ; Medeiros LJ; Tang G
    Hum Pathol; 2024 Feb; 144():71-76. PubMed ID: 38301962
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Comprehensive diagnosis of Mantle Cell Lymphoma].
    Yang H; Guo R; Shi Y; Wang R; Qiao C; Wu YJ; Fan L; Xu W; Li JY; Qiu HR
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1720-1725. PubMed ID: 38071051
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Presence of leukemic clone-specific immunoglobulin heavy chain rearrangements in neonatal blood spots of children with B-cell precursor acute lymphoblastic leukemia.
    Kacanski N; Kolarovic J; Kostic T; Marjanovic I; Janic D; Pavlovic S; Karan-Djurasevic T
    Int J Lab Hematol; 2024 Apr; 46(2):303-311. PubMed ID: 37929321
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
    Quintanilla-Martinez L; Laurent C; Soma L; Ng SB; Climent F; Ondrejka SL; Zamo A; Wotherspoon A; de Leval L; Dirnhofer S; Leoncini L
    Virchows Arch; 2023 Sep; 483(3):281-298. PubMed ID: 37555980
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. 'Evaluation of adverse prognostic gene alterations & MRD positivity in BCR::ABL1-like B-lineage acute lymphoblastic leukaemia patients, in a resource-constrained setting.
    Gupta DG; Varma N; Sreedharanunni S; Abdulkadir SA; Naseem S; Sachdeva MUS; Binota J; Bose P; Malhotra P; Khadwal A; Varma S
    Br J Cancer; 2023 Jul; 129(1):143-152. PubMed ID: 37156894
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Insights into igh clonal evolution in BCP-ALL: frequency, mechanisms, associations, and diagnostic implications.
    Darzentas F; Szczepanowski M; Kotrová M; Hartmann A; Beder T; Gökbuget N; Schwartz S; Bastian L; Baldus CD; Pál K; Darzentas N; Brüggemann M
    Front Immunol; 2023; 14():1125017. PubMed ID: 37143651
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Clinical analysis of 20 cases of small B lymphocyte proliferative disease with t (14;19) (q32;q13)].
    Yang H; Guo R; Shi Y; Qiao C; Wu YJ; Fan L; Xu W; Miao KR; Li JY; Qiu HR
    Zhonghua Xue Ye Xue Za Zhi; 2022 Aug; 43(8):674-679. PubMed ID: 36709153
    [No Abstract]    [Full Text] [Related]  

  • 14. Characterization of Philadelphia-like Pre-B Acute Lymphoblastic leukemia: Experiences in Mexican Pediatric Patients.
    Martínez-Anaya D; Moreno-Lorenzana D; Reyes-León A; Juárez-Figueroa U; Dean M; Aguilar-Hernández MM; Rivera-Sánchez N; García-Islas J; Vieyra-Fuentes V; Zapata-Tarrés M; Juárez-Villegas L; Paredes-Aguilera R; Vega-Vega L; Rivera-Luna R; Juárez-Velázquez MDR; Pérez-Vera P
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076986
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. High occurrence of CRLF2 abnormalities in Mexican children with B-cell acute lymphoblastic leukemia.
    Juárez-Velázquez MDR; Moreno-Lorenzana DL; Martínez Anaya DA; Hernández Monterde EA; Aguilar-Hernández MM; Reyes-León A; Chávez-González MA; López Santiago N; Zapata Tarrés M; Juárez Villegas L; Rivera Sánchez N; Soto Lerma O; Vega-Vega L; Rivera Luna R; Pérez-Vera P
    Cytokine; 2022 Jul; 155():155896. PubMed ID: 35537330
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Clinico-hematological and Outcome Profile of Pediatric B-other-ALL and BCR::ABL1-like pre-B-ALL: An Integrated Genomic Study From North India.
    Peyam S; Bhatia P; Singh M; Sharma P; Sreedharanunni S; Sachdeva MS; Naseem S; Bansal D; Varma N; Thakur R; Trehan A
    Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):e667-e679. PubMed ID: 35484080
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Presentation and Impact of Double and Triple hit Cytogenetics in Patients With Multiple Myeloma in the Real World.
    Singh C; Panakkal V; Sreedharanunni S; Jandial A; Jain A; Lad D; Prakash G; Khadwal A; Malhotra P
    Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):e685-e690. PubMed ID: 35422411
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Chronic Lymphocytic leukemia/Small Lymphocytic Lymphoma With Secondary Acquisition of t(11;14)(q13;q32)/CCND1-igh: A Rare Variant Of Richter Transformation to Mantle Cell Lymphoma.
    Zhao Y; McCracken J; Rehder C; Wang E
    Clin Lymphoma Myeloma Leuk; 2022 May; 22(5):e310-e313. PubMed ID: 34840090
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. High-risk subtypes of chronic lymphocytic leukemia are detectable as early as 16 years prior to diagnosis.
    Kolijn PM; Hosnijeh FS; Späth F; Hengeveld PJ; Agathangelidis A; Saleh M; Casabonne D; Benavente Y; Jerkeman M; Agudo A; Barricarte A; Besson C; Sánchez MJ; Chirlaque MD; Masala G; Sacerdote C; Grioni S; Schulze MB; Nieters A; Engelfriet P; Hultdin M; McKay JD; Vermeulen RCH; Langerak AW
    Blood; 2022 Mar; 139(10):1557-1563. PubMed ID: 34662377
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. DMG26: A Targeted Sequencing Panel for Mutation Profiling to Address Gaps in the Prognostication of Multiple Myeloma.
    Cutler SD; Knopf P; Campbell CJV; Thoni A; Abou El Hassan M; Forward N; White D; Wagner J; Goudie M; Boudreau JE; Kennedy BE; Gujar S; Gaston D; Elnenaei MO
    J Mol Diagn; 2021 Dec; 23(12):1699-1714. PubMed ID: 34562616
    [TBL] [Abstract] [Full Text] [Related]  

    [Next]

    of 15.